• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA 4.35% 12.0¢

AROVELLA THERAPEUTICS LIMITED

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ALA 26/04/24 3 1.1K
26/04/24 Last post  abitlikeme Comments Created with Sketch.  3  Views Created with Sketch.  1.1K 
ALA 23/04/24 0 266
23/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  266 
ALA 23/04/24 62 26K
23/04/24 Last post  Uttsy Comments Created with Sketch.  62  Views Created with Sketch.  26K 
ALA
Latest technical for ALA - Arovella Therapeutics: Chart Inside
12/04/24 0 381
12/04/24 Last post  TheUnit Comments Created with Sketch.  0  Views Created with Sketch.  381 
ALA 10/04/24 1 504
10/04/24 Last post  abitlikeme Comments Created with Sketch.  1  Views Created with Sketch.  504 
ALA 09/04/24 1 855
09/04/24 Last post  amgbenz Comments Created with Sketch.  1  Views Created with Sketch.  855 
ALA 08/04/24 34 13K
08/04/24 Last post  3up Comments Created with Sketch.  34  Views Created with Sketch.  13K 
ALA 04/04/24 0 262
04/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  262 

See All Discussions arrow Created with Sketch.

Timeline

Proposed issue of securities - ALA
23 Apr 13:41
 
Notice of Extraordinary General Meeting/Proxy Form
23 Apr 13:26
 
Notification regarding unquoted securities - ALA
10 Apr 13:51
 
Arovella presents ALA-101 data at AACR
09 Apr 08:56
 
Notice Under Section 708A
04 Apr 11:04
 
Application for quotation of securities - ALA
04 Apr 10:45
 
View More arrow Created with Sketch.
(20min delay)
Last
12.0¢
Change
0.005(4.35%)
Mkt cap ! $126.0M
Open High Low Value Volume
11.5¢ 13.0¢ 11.5¢ $375.7K 3.063M

Buyers (Bids)

No. Vol. Price($)
1 30000 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 114024 2
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
12.0¢
  Change
0.005 ( 4.35 %)
Open High Low Volume
11.8¢ 13.5¢ 11.8¢ 2914423
Last updated 15.47pm 26/04/2024 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.